ADMA BioCenters Tech Stack

FDA-licensed plasma collection and specialty biopharmaceutical manufacturing

Pharmaceutical Manufacturing Roswell, Georgia 201–500 employees Founded 2009 Public Company

ADMA BioCenters operates FDA-licensed plasma donation facilities as a wholly-owned subsidiary of ADMA Biologics, a biopharmaceutical manufacturer focused on plasma-derived therapeutics for infectious disease prevention. The hiring mix is heavily weighted toward manufacturing (27 roles) and healthcare (23 roles) with acute focus on compliance, validation, and operational scaling—reflected in active projects spanning cGMP standardization, facility validation, and training curriculum rollout. Pain points cluster around SOP adherence, donor workflow efficiency, and equipment validation, suggesting a maturing manufacturing operation scaling compliance infrastructure.

Tech Stack 14 technologies

Core StackSAP Smartsheet Adobe Premiere Pro Blackline LIMS HPLC GCP Microsoft Office Microsoft Project SharePoint Word Excel GroupWise XBRL

What ADMA BioCenters Is Building

◆Challenges

Ensuring compliance with sops
Improving donor workflow efficiency
Reducing screening errors
Month end close optimization
Investigating validation deviations
Resolving manufacturing floor issues
Regulatory submissions
High-pressure deadlines
Reducing equipment downtime
Managing capital projects within budget

▲Active Projects

Month end close optimization initiative
Quality systems and cgmp initiatives
Training metrics development
Training curriculum for specific roles
Qa sop review and revision
Capital engineering projects
Centralized site-wide cgmp training program
Validation of facilities and utilities
Equipment validation
Computer system validation

Hiring Activity

Accelerating80 roles · 80 in 30d

Department

Manufacturing

Healthcare

Ops

Engineering

Finance

Operations

Regulatory

Research

Seniority

Junior

Mid

Senior

Manager

Director

Intern

Notable leadership hires: Business Director

Company intelligence

Find more companies like ADMA BioCenters by tech stack, pain points and active projects

Get started free

About ADMA BioCenters

ADMA BioCenters collects human plasma from donors at FDA-licensed facilities, which serves as the raw material for ADMA Biologics' specialty plasma-derived medications targeting infectious disease treatment in immunocompromised and at-risk populations. The company operates a 201–500-person organization headquartered in Roswell, Georgia, structured primarily around manufacturing, healthcare operations, and regulatory functions. Current operational priorities center on quality systems modernization (cGMP initiatives, SOP revision), facility and equipment validation, and month-end financial close optimization. Tech stack leans on SAP for enterprise resource management, LIMS and HPLC for laboratory workflows, and standard office and documentation tools.

HeadquartersRoswell, Georgia

Company Size201–500 employees

Founded2009

Hiring MarketsUnited States

Frequently Asked Questions

What is ADMA BioCenters' main business?

ADMA BioCenters operates FDA-licensed plasma collection facilities that supply human plasma to ADMA Biologics for manufacturing specialty plasma-derived medications to treat and prevent infections in immune-compromised patients.

What tech does ADMA BioCenters use?

Core systems include SAP (enterprise resource planning), LIMS and HPLC (laboratory information and analytical instrumentation), Blackline (financial close), and GCP cloud infrastructure, alongside standard Microsoft Office and SharePoint.